ClinicalTrials.Veeva

Menu

Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program

Masimo logo

Masimo

Status

Terminated

Conditions

Opioid Use

Treatments

Device: Masimo SafetyNet Alert (MSNA)

Study type

Interventional

Funder types

Industry

Identifiers

NCT06217380
SAFE0004

Details and patient eligibility

About

This Clinical Trial will evaluate the Feasibility and Acceptability of Oxygen Saturation Monitoring using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Client Participants:

  • Participants who are18 years of age or greater
  • Participants housed within a supportive housing program who intend to inject opioids
  • Participants who have given verbal informed consent to participate in the study

Inclusion Criteria for Staff Participants:

  • Participant is research staff and/or Rita Thompson Residence staff
  • Participant is willing to give implied consent by reading and completing the staff survey

Exclusion Criteria for Client Participants:

  • Participants deemed not suitable for the study at the discretion of the principal investigator, research staff or housing program nurses/staff
  • Participants with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as psoriasis, eczema, angioma, burns, scar tissue, substantial skin breakdown, nail polish, acrylic nails, infections, or other abnormalities that may interfere with MSNA functioning
  • Participants with known allergic reactions to foam/rubber products and/or adhesive tape

Exclusion Criteria for Staff Participants:

-None

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Masimo SafetyNet Alert (MSNA)
Experimental group
Description:
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo SafetyNet Alert (MSNA)
Treatment:
Device: Masimo SafetyNet Alert (MSNA)

Trial contacts and locations

1

Loading...

Central trial contact

Chelsea Frank

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems